Impact of sink conditions on drug release behavior of controlled-release formulations
Journal of Pharmaceutical Sciences · 2025-01 · 114 (1) · 520-529
DOI: 10.1016/j.xphs.2024.10.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2025-01. Verfasst von Siddhi S Hate und 2 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN 46285, USA. Electronic address: shate@lilly.com. Hauptthemen laut MEDLINE: Delayed-Action Preparations, Drug Liberation, Solubility. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Developing a controlled release (CR) formulations is a complex and iterative process, often requiring preclinical or clinical studies to establish in vitro-in vivo correlations. This can be particularly challenging for poorly soluble drugs due to the non-sink conditions encountered in vitro. Although compendial dissolution methods (e.g., USP II, IV) have historically been used to understand the dissolution performance of CR formulations, there is increasing interest in more physiologically relevant experimental techniques to improve the predictive ability. In this study, traditional USP apparatus as well as the biorelevant absorptive dissolution apparatus were employed to understand the impact of apparatus type and sink condition on the release mechanisms of CR formulations and in turn evaluate the application of absorptive dissolution apparatus for dissolution testing of CR formulations. Release mechanisms were further analyzed using the Peppas equations, providing additional mechanistic insights. The release behavior showed a strong dependence on sink conditions for drugs with low intrinsic solubility, while highly soluble drugs were unaffected by dissolution conditions. Interestingly, the dissolution mechanism was found to be independent of the apparatus type. The study clearly underscores the importance of considering the sink conditions in developing more predictive and biorelevant dissolution testing methods for CR formulations. Furthermore, the study highlights the potential impact on the sink and resultant differences in the drug release mechanisms as a function of the dose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Synthetic Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN 46285, USA. Electronic address: shate@lilly.com.
- Division of Molecular Pharmaceutics and Drug Delivery, The University of Texas at Austin, Austin, TX 78712, USA.
- Synthetic Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Förderung
- Eli Lilly and Company
Zitieren
APA
Hate, S. S., Thompson, S. A., & Singaraju, A. B. (2025). Impact of sink conditions on drug release behavior of controlled-release formulations. Journal of Pharmaceutical Sciences, 114(1), 520-529. https://doi.org/10.1016/j.xphs.2024.10.032
Vancouver
Hate SS, Thompson SA, Singaraju AB. Impact of sink conditions on drug release behavior of controlled-release formulations. Journal of Pharmaceutical Sciences. 2025;114(1):520-529. doi:10.1016/j.xphs.2024.10.032
BibTeX
@article{Hate2025,
author = {Hate, Siddhi S and Thompson, Stephen A and Singaraju, Aditya B},
title = {Impact of sink conditions on drug release behavior of controlled-release formulations},
journal = {Journal of Pharmaceutical Sciences},
year = {2025},
volume = {114},
number = {1},
pages = {520--529},
doi = {10.1016/j.xphs.2024.10.032}
}
EUVIMED